How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,145 results for

E/M Established Outpatient Visit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Prostate Cancer

Prostate Cancer Prostate Cancer | Uroweb › Prostate Cancer Prostate Cancer To access the pdfs & translations of individual guidelines, please as EAU member. Non-EAU members can view the web versions. To become an EAU member, click . N. Mottet (Chair), R.C.N. van den Bergh, E. Briers (Patient Representative), P. Cornford (Vice-chair), M. De Santis, S. Fanti, S. Gillessen, J. Grummet, A.M. Henry, T.B. Lam, M.D. Mason, T.H. van der Kwast, H.G. van der Poel, O. Rouvière, D. Tilki, T. Wiegel (...) Guidelines Associates: T. Van den Broeck, M. Cumberbatch, N. Fossati, T. Gross, M. Lardas, M. Liew, L. Moris, I.G. Schoots, P-P.M. Willemse TABLE OF CONTENTS REFERENCES 1. Drost, F.J.H., et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database of Systematic Reviews, 2019. In press. 2. Van den Broeck, T., et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

2020 European Association of Urology

142. Acute Nonspecific Chest Pain-Low Probability of Coronary Artery Disease

: chest radiography, multidetector computed tomography (MDCT), magnetic resonance imaging (MRI), ventilation/perfusion (V/Q) scans, cardiac perfusion scintigraphy, transesophageal and transthoracic echocardiography, positron emission tomography (PET), spine and rib radiography, barium esophageal and upper GI studies, and abdominal ultrasound (US) [5,6]. Traditionally, most of these examinations have been performed during the ED visit, but there is a trend to perform outpatient testing. Variant: Acute (...) ; James K. Min, MD 9 ; Kalpesh K. Panchal, MD 10 ; Arthur E. Stillman, MD, PhD 11 ; Pamela K. Woodard, MD 12 ; Jill E. Jacobs, MD. 13 Summary of Literature Review Introduction/Background Patients who present to the emergency department (ED) with acute chest pain are stratified according to their probability of developing acute coronary syndrome (ACS) as follows: very low ( 8%) probability [1]. This document outlines the usefulness of available diagnostic imaging for those patients without known

2020 American College of Radiology

143. Acute Trauma to the Ankle

pertinent articles dealing with patients with ankle injuries. The reviewed papers were primarily concerned with missed fractures and improving fracture detection [1-4] or with the establishment of clinical criteria that would decrease the number of ankle radiographs without missing significant injuries [5-15]. Ankle injuries are frequently diagnosed and treated in United States emergency departments (ED) with an incidence of approximately 200 visits per 100,000 person-years [16,17]. Of patients (...) : Timothy J. Mosher, MD 1 ; Mark J. Kransdorf, MD 2 ; Ronald Adler, MD, PhD 3 ; Marc Appel, MD 4 ; Francesca D. Beaman, MD 5 ; Stephanie A. Bernard, MD 6 ; Michael A. Bruno, MD 7 ; Molly E. Dempsey, MD 8 ; Ian Blair Fries, MD 9 ; Viviane Khoury, MD 10 ; Bharti Khurana, MD 11 ; Catherine C. Roberts, MD 12 ; Michael J. Tuite, MD 13 ; Robert J. Ward, MD 14 ; Adam C. Zoga, MD 15 ; Barbara N. Weissman, MD 16 Summary of Literature Review Introduction/Background The musculoskeletal expert panel reviewed

2020 American College of Radiology

144. HRS White Paper on Atrial Fibrillation Centers of Excellence: Rationale, Considerations, and Goals

modification, education, and counseling: comprehensive care Usual care retrospective AF-related ED visits and CV hosp.: 7.5% in CR, 16.8% in AFC, and 29.2% in usual care group. Propensity-matched analysis: CR best compared with usual care OR 4.91 (95% CI 2.09– 11.53) and compared with AFC 2.75 (1.14–6.6) Hendriks et al 2019 108 RCT: 712 pts, 67y, 41% female; mean FU 22 months; single center, outpatient department new- onset AF pts; post hoc analysis Nurse-led care with guideline-based, software supported (...) Osorio, MD, FHRS, Douglas L. Packer, MD, FHRS, Christian Ruff, MD, Andrea M. Russo, MD, FHRS, Prashanthan Sanders, MBBS, PhD, FHRS, Amber Seiler, MSN, NP, FHRS, CEPS, CCDS, David Slotwiner, MD, FHRS, Mellanie True Hills, CSP, Mintu P. Turakhia, MD, MS, FHRS, Isabelle C. Van Gelder, MD, PhD, Paul D. Varosy, MD, FHRS, Atul Verma, MD, FHRS, Annabelle S. Volgman, MD, Kathryn A. Wood, PhD, RN, Thomas Deneke, MD, PhD, FHRS (Vice-Chair) PII: S1547-5271(20)30407-0 DOI: https://doi.org/10.1016/j.hrthm

2020 Heart Rhythm Society

145. Interventions for Substance Use Disorders in Adolescents: A Systematic Review

-00002-I Prepared by: Brown Evidence-based Practice Center Providence, RI Investigators: Dale W. Steele, M.D., M.Sc. Sara J. Becker, Ph.D. Kristin J. Danko, Ph.D. Ethan M. Balk, M.D., M.P.H. Ian J. Saldanha, M.B.B.S., M.P.H., Ph.D. Gaelen P. Adam, M.L.I.S., M.P.H. Sarah M. Bagley, M.D., M.Sc. Catherine Friedman, M.D. Anthony Spirito, M.D. Kelli Scott, Ph.D. Evangelia E. Ntzani, M.D. Iman Saeed, Sc.M. Bryant Smith, M.S., C.P.H. Jonah Popp. Ph.D. Thomas A. Trikalinos, M.D., Ph.D. AHRQ Publication (...) evidence from clinical studies. For more information about AHRQ EPC systematic reviews, see https://effectivehealthcare.ahrq.gov/about/epc/evidence-synthesis. AHRQ expects that these systematic reviews will be helpful to health plans, providers, purchasers, government programs, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions

2020 Effective Health Care Program (AHRQ)

146. Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic

to scheduled visit), and again at registration or as they enter the clinic. • Check each patient’s temperature and ask about symptoms when they arrive to the clinic or registration desk. o Patients with fever (>38 °C) or symptoms should be referred to the hospital’s protocol for symptomatic patients. • Consider evaluating patients with COVID-19 symptoms or known exposure in an outpatient clinic or a site dedicated for this purpose. PPE should be prioritized to that site. Patients with COVID-19 symptoms (...) to schedule as circumstances allow, although an arbitrary delay of 2 months is reasonable. o Discuss the risks and benefits of delaying surveillance with the patient and document the discussion. o These patients should be prioritized for imaging studies as outpatient facilities start to re-open. • Review images of new referrals for patients with liver masses in tumor board or with expert radiologists in virtual multidisciplinary conference prior to scheduling an in-person visit. • Consider virtual visits

2020 American Association for the Study of Liver Diseases

147. Key Questions on COVID-19 and Cardiovascular Disease

consider these practical management strategies to facilitate care. Author: Nicole M. Orr, MD, FACC, and select members of the ACC Geriatric Member Section Source: SQC Approval Date: April 24, 2020 Many older adults fearful of COVID-19 are strictly adherent to social isolation measures and may be avoiding routine medical care. Continued management of cardiac disease during the pandemic is essential as optimization of cardiovascular health may not only decrease the risk of a cardiac admission (...) but potentially mitigate vulnerability if exposed to SARS-CoV-2. Patients should be contacted to avoid canceling appointments and encouraged to reschedule via telehealth encounters when feasible. Older adults may have difficulty navigating audio-visual technology, so patients and families should be encouraged to familiarize themselves with a video platform to which they have access and feel comfortable using. Telephone visits should be maintained and will be reimbursed if patients cannot or do not wish to use

2020 American College of Cardiology

148. Adult liver transplantation: A UK clinical guideline – part 1: pre-operation

Adult liver transplantation: A UK clinical guideline – part 1: pre-operation 1 Millson C, et al. Frontline Gastroenterology 2020;0:1–10. doi:10.1136/flgastro-2019-101215 Review Adult liver transplantation: A UK clinical guideline - part 1: pre- operation Charles Millson , 1 Aisling Considine, 2 Matthew E Cramp, 3 Andrew Holt, 4 Stefan Hubscher, 5 John Hutchinson, 6 Kate Jones, 7 Joanna Leithead, 8 Steven Masson, 9 Krish Menon, 10 Darius Mirza, 11 James Neuberger, 12 Raj Prasad, 13 Anthony Pratt (...) , 14 Wendy Prentice, 15 Liz Shepherd, 16 Ken Simpson, 17 Doug Thorburn, 18 Rachel Westbrook, 19 Dhiraj Tripathi 20 Liv ER To cite: Millson C, Considine A, Cramp ME, et al. Frontline Gastroenterology Epub ahead of print: [please include Day Month Year]. doi:10.1136/ flgastro-2019-101215 ? Additional material is published online only. To view please visit the journal online (http:// dx. doi . org/ 10. 1136/ flgastro- 2019- 101215). For numbered affiliations see end of article. Correspondence to Dr

2020 British Society of Gastroenterology

149. What is the evidence base for care models within care homes that improve the end of life for patients and their carers?

, there was a five -fold increase in hospital admission rates across intervention and control groups, but the intervention group had statistically significantly fewer admissions than control. There was no di ffe rence in A&E attendance between the intervention and control groups. However the intervention group had a higher rate of outpatient visits. Appraisal Summary This project suggests that the implementation of a complex care hub, following a chronic disease management model, may impact on hospital (...) model reduced end of life admissions by 36%, but outpatient visits increased and heterogeneity across homes was high. Carer burden and satisfaction with care were specific domains of interest for the review. Three studies included carer outcomes of interest. For dementia patients there was limited evidence that early confirmation of a comfort care goal (van Soest-Poortvliet et al.,2015) and improved staff skills in symptom management and communication (Verrault et al., 2018) may improve family

2020 Palliative Care Evidence Review Service (PaCERS)

150. Pharmacological management of migraine

Abbreviations 34 Annexes 35 References 42 Pharmacological management of migraine Pharmacological management of migraine| 1 1 Introduction 1.1 THE NEED FOR A GUIDELINE Headache is common, with a lifetime prevalence of over 90% of the general population in the United Kingdom (UK). 1 It accounts for 4.4% of consultations in primary care and 30% of neurology outpatient consultations. 1-4 Headache disorders are classified as either primary or secondary. 5 Primary headache disorders are not associated (...) and Therapeutics Committees about the status of all newly-licensed medicines, all new formulations of existing medicines and new indications for established products. NHSScotland should take account of this advice and ensure that medicines accepted for use are made available to meet clinical need where appropriate. SMC advice relevant to this guideline is summarised in section 8.4. Pharmacological management of migraine| 5 2 Key recommendations The following recommendations were highlighted by the guideline

2018 SIGN

151. Promonitor for monitoring response to biologics in rheumatoid arthritis

making and included: costs for non-optimal treatment; outpatient and specialist visits, laboratory costs; cost of resources; and societal costs. Key outcomes The Markov model shows that after 3 years, 40% of people having adalimumab and 50% of people having infliximab would need drug treatment modifications. Costs incurred from non-optimal treatment were €1,471 per month and accumulated on clinical follow-up visits. The authors suggest that drug levels should be monitored regularly for all people (...) Promonitor for monitoring response to biologics in rheumatoid arthritis Promonitor for monitoring response to biologics Promonitor for monitoring response to biologics in rheumatoid arthritis in rheumatoid arthritis Medtech innovation briefing Published: 27 October 2017 nice.org.uk/guidance/mib126 pathways Summary Summary The technology technology described in this briefing is Promonitor. It is used to monitor response to biologic therapies. The inno innovativ vative aspect e aspect

2017 National Institute for Health and Clinical Excellence - Advice

152. Deprescribing benzodiazepine receptor agonists

if considering deprescribing Continue AP Good practice recommendation Stop AP Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). deprescribing@bruyere.org or visit deprescribing.org for more information. Figure 1 Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une (...) , McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). deprescribing@bruyere.org or visit deprescribing.org for more information. Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une à deux semaines pendant la réduction graduelle Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman Wilms L, Rojas

2018 CPG Infobase

153. Management of opioid use disorders: a national clinical practice guideline

, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy 2017;46:172-9. 2. Canadian Institute for Health Information, Canadian Centre on Substance Abuse. Hospitalizations and emergency department visits due to opioid poison- ing in Canada. Ottawa: Canadian Institute for Health Information; 2016. 3. Bruneau J, Roy E, Arruda N, et al. The rising prevalence of prescription opioid injection and its association with hepatitis C (...) management (without transition to opioid agonist treatment) is pursued, provide supervised slow (> 1 mo) opioid agonist taper (in an outpatient or residential treatment setting) rather than a rapid (< 1 wk) taper. During opioid-assisted withdrawal management, patients should be transitioned to long-term addiction treatment† to help prevent relapse and associated health risks. Moderate Strong 8. For patients with a successful and sustained response to opioid agonist treatment who wish to discontinue

2018 CPG Infobase

154. Diagnosis and management of epilepsy in adults

indications for established products. SMC advice relevant to this guideline is summarised in section 11.4. Diagnosis and management of epilepsy in adults 1 • Introduction 4 | 2 Key recommendations The following recommendations were highlighted by the guideline development group as the key clinical recommendations that should be prioritised for implementation. The grade of recommendation relates to the strength of the supporting evidence on which the recommendation is based. It does not reflect (...) time for the patient and by an appropriate healthcare professional (consultant neurologist, physician with an interest in epilepsy, specialist registrar, or epilepsy nurse specialist). 2.7 MODELS OF CARE D A structured management system for patients with epilepsy should be established in primary care. As with other chronic diseases, an annual review is desirable. Diagnosis and management of epilepsy in adults 2 • Key recommendations6 | 3 Diagnosis 3.1 WHO SHOULD MAKE THE DIAGNOSIS OF EPILEPSY

2018 SIGN

155. Public health service provision by community pharmacies: a systematic map of evidence

: This report should be cited as: Stokes G, Rees R, Khatwa M, Stansfield C, Burchett H, Dickson, K, Brunton G, Thomas J (2019) Public health service provision by community pharmacies: a systematic map of evidence. London: EPPI-Centre, Social Science Research Unit, Institute of Education, University College London. Funding This report is independent research commissioned by the National Institute for Health Research (NIHR) Policy Research Programme (PRP) for the Department of Health and Social Care (DHSC (...) with a global agenda for improving healthy life expectancy through accessible, multi-disciplinary networks of community-based healthcare professionals (World Health Organization 2004; DH 2008). It is estimated there are 11,619 community pharmacies across England. It is estimated that 1.6 million people visit a pharmacy every day and that 1.2 million of these visits are for health-related reasons. (LGA 2013; PSNC 2013a). Community pharmacies are easily accessible to people seeking local healthcare (PHE 2014

2019 EPPI Centre

156. What helps to support people affected by Adverse Childhood Experiences? A Review of Evidence

of this report. Contributions The opinions expressed in this publication are not necessarily those of the EPPI-Centre or the funders. Responsibility for the views expressed remains solely with the authors. This report should be cited as: Lester S, Lorenc T, Sutcliffe K, Khatwa M, Stansfield C, Sowden A, Thomas J (2019) What helps to support people affected by Adverse Childhood Experiences? A Review of Evidence. London: EPPI-Centre, Social Science Research Unit, UCL Institute of Education, University College (...) synthesis 90 Studies not obtained in time (n=7) 90 Studies excluded on title and abstract (n=166) 90 Studies excluded on full text (n=34) 100 Studies excluded following quality and relevance appraisal (n=10) 102 Appendix E: Evidence tables for studies included in the views synthesis (n=21) 103 Appendix F: Results of Quality Appraisal (overview) 119 Appendix G: Evidence Tables (overview) 126 Appendix H: Lists of Excluded Studies (overview) 180 Studies excluded from the best-evidence synthesis on account

2019 EPPI Centre

157. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review Full Text available with Trip Pro

Open Access Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review Corresponding Author E-mail address: Corresponding author Emily A. Hennessy Institute for Collaboration on Health Intervention & Policy University of Connecticut 2006 Hillside Road Storrs, CT, 06269 USA E‐mail: Corresponding Author E-mail address: Corresponding author Emily A. Hennessy Institute for Collaboration on Health Intervention & Policy (...) University of Connecticut 2006 Hillside Road Storrs, CT, 06269 USA E‐mail: First published: 04 October 2018 Linked article: . Give access Share full text access Please review our and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use. Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link Share on ). Although not every youth who experiments

2018 Campbell Collaboration

158. Effectiveness of interventions to reduce homelessness: a systematic review and meta?analysis Full Text available with Trip Pro

and meta‐analysis Corresponding Author E-mail address: Corresponding author: Heather Menzies Munthe‐Kaas, Norwegian Institute of Public Health, Division for health services, PO Box 4404, Nydalen, N‐0403 Oslo, Norway, E‐mail: Corresponding Author E-mail address: Corresponding author: Heather Menzies Munthe‐Kaas, Norwegian Institute of Public Health, Division for health services, PO Box 4404, Nydalen, N‐0403 Oslo, Norway, E‐mail: First published: 28 February 2018 Give access Share full text access Please (...) combinations. Evaluations are typically based on comparison of one type of combination with another, or with “usual care” (often drop in centres, after care services, outpatient clinics, brokered case management, etc.). This means that housing programs are often not implemented and evaluated in similar forms. Any effort to analyse and synthesize evaluations of housings programs, case management and other included services, must therefore consider this complexity and lack of clarity. In addition

2018 Campbell Collaboration

159. Corticosteroids for treatment of sore throat Full Text available with Trip Pro

. Some patients with sore throat also experience headache, fever, muscle stiffness, cough, and general malaise. Acute sore throat is common, but only a minority of patients will visit their general practitioner. A survey reported that the main reasons are to establish the cause of the symptoms, obtain pain relief, and to gain information on the course of the disease. Data from Dutch and Flemish primary care databases show that, for every 1000 consecutive patients consulting a general practitioner, 50 (...) Guidelines Network. Management of sore throat and indications for tonsillectomy (SIGN 117). 2010. . Little P, Stuart B, Hobbs FD, et al. DESCARTE investigators. Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. . Atula T. Corticosteroids for sore throat. Evidence-Based Medicine Guidelines . 2014. . Ebell MH, Smith MA, Barry HC, Ives K, Carey M. The rational clinical examination. Does this patient have strep throat? . Chiappini E, Regoli M

2017 BMJ Rapid Recommendations

160. Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies

time, alternative causes of anxiety such as mood or substance use disorders, physical illness or its treatment should be considered (Lampe, 2015; McEvoy et al., 2011). Anxiety disorders are associated with high levels of dis- tress, disability and service use (Slade et al., 2009b), yet only a minority of people with anxiety disorders get ade- quate treatment (Harris et al., 2015). Fewer than half seek treatment by visiting a health professional. Those who do, commonly attend primary care and only (...) management of anxiety disorders also involves consideration of issues for people in various age groups, sociocultural diversity, issues for indigenous cultures, and important comorbidities. First published in the Australian and New Zealand Journal of Psychiatry 2018, Vol. 52(12) 1109-1172.1118 ANZJP Articles Structured clinical interviews. There are four well-established diagnostic interviews that generate a reliable and valid diagnosis: • • Structured Clinical Interview for Axis 1 DSM-IV Disorders

2018 Royal Australian and New Zealand College of Psychiatrists

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>